Lupin has received USFDA approval for its biosimilar Armlupeg (pegfilgrastim-unne) injection, to be manufactured at its Pune ...
Pharmaceutical Technology on MSN
US FDA approves Lupin’s Armlupeg injection
Lupin has FDA approval for Armlupeg 6mg/0.6ml injection in a single-dose prefilled syringe, for subcutaneous use, as a ...
The US drug regulator has approved the Armlupeg (pegfilgrastim-unne) 6mg / 0.6 ml injection for subcutaneous use in a ...
Lupin has secured its first US biosimilar approval with Armlupeg, a pegfilgrastim product manufactured at its Pune facility, ...
Lupin receives USFDA approval for Armlupeg, a biosimilar to Neulasta, used to treat neutropenia in cancer patients. Read more ...
Drugmaker Lupin has received U.S. Food and Drug Administration approval for Armlupeg (pegfilgrastim-unne) 6 mg/0.6 mL injection as biosimilar to Neulasta (pegfilgrastim) 6 mg/0.6 mL injection.
This European palace was once among the world’s most grand — but today is a marvel of decay. Netherlands-based photographer Roman Robroek, 34, has shared photos of his recent visit to France’s ...
Lupin is a well-known garden flower, and is an important part of a healthy habitat. Lupin grows rapidly and puts nutrients back into the soil. (Lupin is commonly referred to as "lupine" for those ...
Lupin receives USFDA approval for Armlupeg, a biosimilar to Neulasta, enhancing treatment options for cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results